Logo Environmental XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
BioFactura, Inc.
About
  2. Companies
  3. BioFactura, Inc.
  4. Services
  5. BioFactura Contract Services

BioFactura Contract Services

SHARE
Biopharmaceutical Development and Manufacturing. BioFactura’s biopharmaceutical industry experience is grounded in bioprocess development, scale-up, and manufacturing. The Company has capabilities to develop a broad range of upstream bioprocesses in mammalian cell culture expression systems. This includes the development of expression vectors and cell lines through medium optimization and process scale-up. BioFactura is also highly experienced in developing downstream recovery and purification processes. Steps may include centrifugation, depth and micro/ultra-filtration, and chromatography (affinity, ion-exchange, hydrophobic interaction). The Company is also well versed in developing and performing in-process and release analytical assays including various HPLC methods, SDS-PAGE and Western analysis, antibody/antigen capture ELISAs, purity assays (endotoxin, HCP, residual protein A), and bioactivity methods.
Most popular related searches
single-use bioreactor
mammalian cell culture
facility monitoring system
cell culture
bioprocess engineering
HPLC method
environmental monitoring
ion exchange
ultrafiltration
cell culture system

BioFactura’s facilities are located at 8435 Progress Drive, Suites Y-Z in Frederick, Maryland. The laboratory space is segregated into a general research lab, an analytical lab, and three cGMP suites at ISO 8 and 7 classification: A cell culture suite (ISO 7: 200 sq. ft.); a bioreactor suite with 250L and 1000L single-use bioreactors (upstream, ISO 8: 235 sq. ft.); and purification suite (downstream, ISO 7: 300 sq. ft.). All critical environmental and process parameters are electronically monitored by a compliant Facility Monitoring System (FMS). Environmental monitoring (EM) is outsourced during cGMP campaigns. All process equipment and bioprocesses utilize full single-use technology such that all product contact surfaces are disposable and no cleaning or in-house sterility validation is required. This delivers high flexibility, rapid changeover, and low failure risk for clinical manufacturing campaigns.